Youth-onset type 2 diabetes mellitus: Lessons learned from the TODAY study

Mayo Clinic Proceedings

Volumn 89, Issue 6, 2014, Pages 806-816

  Narasimhan, Sumana ^a   Weinstock, Ruth S ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIMEPIRIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEMOGLOBIN A1C; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; ROSIGLITAZONE; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ABDOMINAL DISCOMFORT; ANOREXIA; ATHEROSCLEROSIS; BARIATRIC SURGERY; BEHAVIOR CHANGE; BLADDER CANCER; BODY MASS; BODY WEIGHT DISORDER; BONE DENSITY; BONE MINERAL; CARDIOVASCULAR DISEASE; DEPRESSION; DIABETES EDUCATION; DIARRHEA; DYSLIPIDEMIA; EDEMA; FRACTURE; FUNGAL GENITAL INFECTION; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; HYPOTENSION; INSULIN SENSITIVITY; INSULIN TREATMENT; KETOACIDOSIS; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; MICROALBUMINURIA; MONOTHERAPY; MULTICENTER STUDY (TOPIC); NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREATITIS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOPATHY; REVIEW; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; BLOOD GLUCOSE; CHILD; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; METFORMIN; OBESITY; RISK REDUCTION BEHAVIOR; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 84904763852     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.01.009     Document Type: Review

References (54)

1. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55(6):1832-1839.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: Department of Health and Human Services; 2011.
3. Jacobs MJ, Kleisli T, Pio JR, et al. Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Res Clin Pract. 2005;70(3):263-269.
4. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23(11): 1165-1173.
5. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(suppl):S164-S192.
6. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
7. Steinberger J, Moran A, Hong CP, Jacobs DR Jr, Sinaiko AR. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr. 2001;138(4):469-473.
8. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961-969.
9. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab. 2000;13(suppl 6):1395-1402.
10. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulindependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5):608-615.
11. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics. 1997;100(1):84-91.
12. Pihoker C, Scott CR, Lensing SY, Cradock MM, Smith J. Noninsulin dependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr. 1998;37(2):97-102.
13. Hale DE, Rupert G. The changing spectrum of diabetes in Mexican American youth. Rev Endocr Metab Disord. 2006; 7(3):163-170.
14. Dabelea D, Ra Bell, D'Agostion RB Jr, et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297(24): 2716-2724.
15. Pettitt DJ, Talton J, Dabelea D, et al. Prevalence of diabetes mellitus in U.S. youth in 2009: the SEARCH for Diabetes in Youth Study [published online September 16, 2013]. Diabetes Care. 2013.
16. American Diabetes Association. Standards of medical care in diabetes: 2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
17. Weiss R, Taksali DE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28(4):902-909.
18. Ali MK, Bullard KM, Beckles GL, et al. Household income and cardiovascular disease risks in U.S. children and young adults: analyses from NHANES 1999-2008. Diabetes Care. 2011; 34(9):1998-2004.
19. Zeitler P, Epstein L, Grey M, et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007;8(2):74-87.
20. Zeitler P, Hirst K, Pyle L, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012; 366(24):2247-2256.
21. TODAY Study Group. Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study. Int J Obes (Lond). 2010;34(2):217-226.
22. Anderson BJ, Edelstein S, Abramson NW, et al. Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study. Diabetes Care. 2011;34(10):2205-2207.
23. Wilfley D, Berkowitz R, Goebel-Fabbri A, et al. Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the today study. Diabetes Care. 2011;34(4):858-860.
24. TODAY Study Group. Treatment effects on measures of body composition in the TODAY clinical trial. Diabetes Care. 2013; 36(6):1742-1748.
25. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and beta-cell function in TODAY. Diabetes Care. 2013;36(6): 1749-1757.
26. Kahn SE, Lachin JM, Zinman B, et al. Effects of rosiglitazone, glyburide, and metformin on b-cell function and insulin sensitivity in ADOPT. Diabetes. 2011;60(5):1552-1560.
27. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC; UK Prospective Diabetes Study (UKPDS) Group. UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabet Med. 1998;15(4):297-303.
28. Kahn SE, Montgomery B, Howell W. Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2001; 86(12):5824-5829.
29. Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr. 2005;147(1): 67-73.
30. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care. 2007;30(10):2593-2598.
31. Farrah SE, Wals KT, Friedman IB, Pisacano MA, DiMartino-Nardi J. Prevalence of retinopathy and microalbuminuria in pediatric type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2006; 19(7):937-942.
32. Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6):1300-1306.
33. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA. 2006;296(4): 421-426.
34. Mayer-Davis EJ, Davis C, Saadine J, et al; SEARCH for Diabetes in Youth Study Group. Diabetic retinopathy in the SEACH for Diabetes in Youth cohort: a pilot study. Diabet Med. 2012; 29(9):1148-1152.
35. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36(6):1735-1741.
36. TODAY Study Group. Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care. 2013;36(6):1772-1774.
37. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Program. Diabet Med. 2007;24(2): 137-144.
38. Lim LS, Tai ES, Mitchell P, et al. C-reactive protein, body mass index and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010; 51(9):4458-4463.
39. Hillier TA, Pedula KL. Complication in young adults with earlyonset type 2 diabetes: losing the relative protection of youth. Diabetes Care. 2003;26(11):2999-3005.
40. Gungor N, Thomposon T, Sutton-Tyrrell K, Janosky J, Arslanian S. Early signs of cardiovascular disese in youth with obesity and type 2 diabetes. Diabetes Care. 2005;28(5):1219-1221.
41. Davis PH, Dawson JD, Riley WA, Lauer RM. Carotid intimalmedial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation. 2001;104(23):2815-2819.
42. Shah AS, Dolan LM, Kimball TR, et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metabol. 2009;94(10):3740-3745.
43. Petitti DB, Imperatore G, Palla SL, et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med. 2007;161(2):159-165.
44. TODAY Study Group. Lipid and inflammatory cardiovascular risk worsens over 3 years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36(6):1758-1764.
45. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884-1890.
46. Springer SC, Silverstein J, Copeland K, et al. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics. 2013;131(2):e648- e664.
47. Copeland KC, Silverstein J, Moore KR, et al. Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics. 2013;131(5):364-382.
48. Nadeau KJ, Zeitler PS, Bauer TA, et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab. 2009;94(10):3687-3695.
49. Laffel L, Chang N, Grey M, et al. Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the pre-randomization run-in phase of the TODAY study. Pediatr Diabetes. 2012;13(5):385-391.
50. Gottschalk M, Danne T, Vlajnic A, Cara CF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 daibetes: a randomized single-blind comparative study. Diabetes Care. 2007;30(4):790-794.
51. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-1576.
52. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393-411.
53. Michalsky M, Kramer RE, Fullmer MA, et al. Developing criteria for pediatric/adolescent bariatric surgery programs. Pediatrics. 2011;128(suppl 2):S65-S70.
54. Inge TH, Gargia V, Daniels S, et al. A multidisciplinary approach to the adolescent bariatric surgical patient. J Pediatr Surg. 2004; 39(3):442-447; discussion 446-447.